Adding Polivy to Standard of Care Boosts Survival in Relapsed/Refractory DLBCL

(MedPage Today)-Add Polatuzumab Vedotin (Polivy) to the highly normative care treatment. It improved survival in general (OS) in patients with a large Big Lympho B. (DLBCL), and the Polargo experience showed in the third stage …